Dash Bio has raised $30 Million in new Series A funding
According to filings with the U.S. Securities and Exchange Commission, Dash Bio has raised $30 Million in new Series A funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
Investors in the company’s current round of funding include: Oak HC/FT,Freestyle Capital, and Swift Ventures
About Dash Bio
Dash Bio is building the infrastructure that drug development needs for the next generation of medicines. The company has built a bioanalysis platform delivering GLP-compliant results in days through automation and transparent pricing. Founded by industry leaders Dave Johnson (CEO), Ander Tallett (COO), and Ely Porter (CSO), Dash Bio eliminates the bottlenecks that slow drug development by replacing manual processes with automation-first workflows. The company serves biotech companies across all therapeutic areas, offering transparent pricing and rapid turnarounds that accelerate development timelines.
To learn more, visit https://www.dash.bio/
Linkedin: https://www.linkedin.com/company/dashbio/
Contact:
Dave Johnson, Founder
https://www.linkedin.com/in/dave-johnson-60a95142/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.